XTRA:SHLMedical Equipment
Is Siemens Healthineers (XTRA:SHL) Undervalued After Cutting Its 2026 Revenue Growth Outlook?
Siemens Healthineers (XTRA:SHL) cut its 2026 revenue growth guidance to 3.5% to 4% after weaker than expected Diagnostics trends in China and on legacy platforms, sharpening investor focus on the stock’s risk profile.
See our latest analysis for Siemens Healthineers.
Against this guidance cut, Siemens Healthineers’ recent share price performance has been mixed, with shorter term momentum firming. The stock has a 30 day share price return of 14.22% and a 90 day share price return of 16.55%...